Ácido malónico, mínimo 99 %, para síntesis, 100 g, envase de vidrio

Methyl benzo[d][1,3]dioxole-5-carboxylate, 95.0%, 10g

4-Hydroxybicyclo[2.2.2]octane-1-carbaldehyde, 95.0%, 50mg

6-Amino-1-butyl-5-{[(2-methoxyphenyl)methyl]amino}-1,2,3,4-tetrahydropyrimidine-2,4-dione, 97%, 100mg

Óxido de disprosio(III), ROTI®REMETIC, 99,9%, 25 g, envase de plástico.

3-Amino-6-(aminomethyl)-1,2,4-triazin-5(4H)-oneacetate, 95.0%, 25g

5-ACETYL-1,3-DIHYDRO-2H-BENZIMIDAZOL-2-ONE, 95.0%, 2g

4-(2-Benzothiazolyldithio)morpholine>95.0%(N)25g

Dibutylamine, 99.0%, 100g

1,3-Bis((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)propan-1-one  (Ibrutinib Impurity）, 97%, 50mg

2-Phenyl-1H-benzo[d]imidazole, 95.0%, 500g

N-(azepan-2-ylidene)hydroxylamine, 98%, 1g

AURINTRICARBOXYLIC ACID, 95%, 1g